Emerging therapeutic alternatives for snakebite envenoming
Uloženo v:
| Autor: | |
|---|---|
| Médium: | contribución de congreso |
| Datum vydání: | 2019 |
| Popis: | The primary treatment for snakebite envenoming remains the administration of animal-derived antivenoms. While highly effective against systemic manifestations, antivenoms present drawbacks, including the need for trained healthcare staff, limited specificity (being restricted to the venoms used in immunization), and the risk of adverse reactions. |
| Země: | Kérwá |
| Instituce: | Universidad de Costa Rica |
| Repositorio: | Kérwá |
| Jazyk: | Inglés |
| OAI Identifier: | oai:kerwa.ucr.ac.cr:10669/104658 |
| On-line přístup: | https://hdl.handle.net/10669/104658 https://doi.org/10.1016/j.toxicon.2019.06.044 |
| Klíčové slovo: | Snakebite envenoming Antivenoms Recombinant antibodies Toxin inhibitors Phospholipases A2 Metalloproteinases Nanoparticles |